Treatment patterns and outcomes of patients with TP53-mutated chronic lymphocytic leukemia

被引：0
|
作者：
Hwang, Steven
Wang, Yucai
Rabe, Kari
Williams-Watley, Marquise
Kenderian, Saad
Muchtar, Eli
Hampel, Paul
Kay, Neil
Koehler, Amber
Behnken, Amy
Leis, Jose
Braggio, Esteban
Shi, Min
Viswanatha, David
Van Dyke, Daniel
Slager, Susan
Parikh, Sameer
He, Rong
Ding, Wei
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1550290
引用
收藏
页码：S84 / S85
页数：2
相关论文
共 50 条
  • [31] The Current Understanding of and Treatment Paradigm for Newly-Diagnosed TP53-Mutated Acute Myeloid Leukemia
    Shallis, Rory M.
    Stahl, Maximilian
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    Testa, Ugo
    Walter, Roland B.
    HEMATO, 2021, 2 (04): : 748 - 763
  • [32] TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches
    Mariana Pinto Pereira
    Elizabeth Herrity
    Dennis D.H Kim
    Annals of Hematology, 2024, 103 : 1049 - 1067
  • [33] Optimal Induction and Consolidation Strategy for Patients with Complex Karyotype and TP53-Mutated Acute Myeloid Leukemia
    Jamy, Omer H.
    Diebold, Kendall
    Bachiashvili, Kimo
    Rangaraju, Sravanti
    Vachhani, Pankit
    Godby, Kelly N.
    Salzman, Donna
    Bhatia, Ravi
    BLOOD, 2022, 140 : 8959 - 8960
  • [34] Outcomes of Patients with TP53-Mutated Myeloid Neoplasms (TP53-MN) and the Role of Allogenic Blood or Marrow Transplantation (alloBMT)
    Pasca, Sergiu
    Haldar, Saurav D.
    Ambinder, Alexander J.
    Webster, Jonathan
    Jain, Tania
    Dalton, William Brian
    Prince, Gabrielle T.
    Ghiaur, Gabriel
    DeZern, Amy E.
    Gojo, Ivana
    Webster, Jonathan Allen
    Schulz, Cory
    Stokvis, Kristin
    Levis, Mark J.
    Jones, Richard J.
    Gondek, Lukasz P.
    BLOOD, 2022, 140 : 10629 - 10631
  • [35] Evaluating targeted therapies in older patients with TP53-mutated AML
    Sabile, Jean M. G.
    Swords, Ronan
    Tyner, Jeffrey W.
    LEUKEMIA & LYMPHOMA, 2024, 65 (09) : 1201 - 1218
  • [36] Treatment outcomes for newly diagnosed, treatment-naive TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis
    Daver, Naval G. G.
    Iqbal, Shahed
    Renard, Camille
    Chan, Rebecca J. J.
    Hasegawa, Ken
    Hu, Hao
    Tse, Preston
    Yan, Jiajun
    Zoratti, Michael J. J.
    Xie, Feng
    Ramsingh, Giridharan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [37] TP53-Mutated Acute Myeloid Leukemia Patients Treated with Intensive Therapies Have Superior Outcomes: A Single Institution, Retrospective Study
    Sumransub, Nuttavut
    Steinwand, Gabriel K.
    Lee, Yoonkyu
    Cao, Qing
    Allred, Jeremy R.
    Ramesh, Vidhyalakshmi
    Myers, Chad L.
    Sachs, Zohar
    BLOOD, 2023, 142
  • [38] Managing Patients With TP53-Deficient Chronic Lymphocytic Leukemia
    Edelmann, Jennifer
    Gribben, John G.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (06) : 371 - 378
  • [39] Genomic landscape of TP53-mutated myeloid malignancies
    Abel, Haley J.
    Oetjen, Karolyn A.
    Miller, Christopher A.
    Ramakrishnan, Sai M.
    Day, Ryan B.
    Helton, Nichole M.
    Fronick, Catrina C.
    Fulton, Robert S.
    Heath, Sharon E.
    Tarnawsky, Stefan P.
    Srivatsan, Sridhar Nonavinkere
    Duncavage, Eric J.
    Schroeder, Molly C.
    Payton, Jacqueline E.
    Spencer, David H.
    Walter, Matthew J.
    Westervelt, Peter
    Dipersio, John F.
    Ley, Timothy J.
    Link, Daniel C.
    BLOOD ADVANCES, 2023, 7 (16) : 4586 - 4598
  • [40] How I Treat TP53-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Loschi, Michael
    Fenaux, Pierre
    Cluzeau, Thomas
    CANCERS, 2022, 14 (18)
12345